SlideShare a Scribd company logo
COMMON LAB. INVESTIGATIONS
IN PREGNANCY
With specific reference to Anaemia, Leukocytosis,
Thrombocytopenia, GDM.
Dr. NISHEETH M. OZA
Dr. Nisheeth M. Oza
M.D., D.G.O., F.C.P.S., D.N.B., (M.N.A.M.S.) (OBGYN)
D.A., M.B.B.S., Dip. YAN
Obstetrician, Gynaecologist, Infertility Consultant,
FMF Certified Ultrasonographer (FMF ID 145907)
Licensed for Aneuploidy Screening NT, NB, DV, Cervix & PIH Screening.
Diploma in Yoga, Ayurveda & Naturopathy
Dr. Oza’s Hospital 87/7, Panvel 410206, Maharashtra India.
Email : drnmozas@gmail.com
Website : drozashospital.com
YouTube : DrOzaConnects
INTRODUCTION
When a Lady visits her Doctor during her pregnancy, she may be asked to undergo
certain Laboratory Investigations at several times, e.g.
In her first visit,
At 11-14 weeks,
At 26-28 weeks,
At 34-36 weeks,
She may wonder as to
Whether the Lab. Investigations are necessary?
WHICH? WHEN? WHY?
AIM OF LAB. INVESTIGATIONS – WHY?
• As a part of Prenatal (Antenatal) Care.
• To ascertain the well being of P.W. eg Her Haemoglobin test.
• To find out the conditions that may increase the risk of complications eg GDM
(BS/DIPSI Test), UTI (Urine C/S), Hypothyroidism (S. TSH).
• To find out conditions that may need special care & management eg Rh Negative,
Haemoglobinopathy or STI.
• To find out the conditions that may modify the management of P.W. & her N.B. eg
HIV positive.
WHEN?
• FIRST TRIMESTER/FIRST VISIT :
Antenatal Profile – Antenatal Panel.
May combine it with Genetic Screening Tests at 11-24 weeks.
• SECOND TRIMESTER 24-48 WEEKS :
GDM, UTI, Anaemia.
• THIRD TRIMESTER 35-37 WEEKS :
GBS (Group B Streptococcal Vaginal Culture).
UTI, Anaemia, Pre-eclampsia.
FIRST TRIMESTER/FIRST VISIT LAB. TESTS
MOST IMPORTANT: HbA1C, S. TSH.
MINIMUM : CBC, Bl. Group & Rh type, HbA1C/DIPSI Test, S.TSH. Urine-R/M including
Dipstick (Protein, Sugar, Pus cells, Nitrite).
PREFERABLE : HIV, HBsAg, HCV, VDRL.
BT, CT, PT.
Urine C/S.
OFFERED : Hb Electrophoresis – Abnormal Hb Study (Hb HPLC).
Rapid Malaria Test (kit), Thick & Thin Smear.
PAP Smear (Cytology).
Rubella IgG.
FUTURE : COVID-19 IgG, IgM.
Note: These may be combined with Genetic Screening Tests recommended between 11and 14 weeks, If
not performed prior to that.
SECOND TRIMESTER: 24-28 WEEKS
• CBC
• DIPSI TEST, SOS OGTT
• Urine Dipstick (Protein, Sugar, Pus Cells, Nitrate)
THIRD TRIMESTER: 35-37 WEEKS
• CBC
• Urine Dipstick (Protein, Sugar, Pus Cells, Nitrate)
• SOS Serum Creatinine, Serum Uric Acid
• Group B Streptococcal Vaginal Culture (GBS)
• Before Delivery : As per prevailing Protocol : COVID-19 rt PCR.
WHICH TESTS ? WHAT IS THE SIGNIFICANCE?
A] CBC
COMPONENT CRITICAL VALUE FUNCTIONS
Hb < 8 grams% Carrying Oxygen to Tissues.
WBC > 15,000/cu mm Fighting against Germs.
Platelet Count < 1,00,000/ cu mm Facilitate Blood Clotting.
Mentzer Index < 13 Indicates Possibility of
Haemoglobinopathy.
LOW HB LEVEL: ANAEMIA IN PREGNANCY
FUNCTION OF Hb : Carrying Oxygen to Tissues of P.W. & her fetus.
PHYSIOLOGICAL : Plasma Volume(Liq. Component), more (50%) then RBC Vol.
CHANGES (Solid Component) (30%), thereby Haemodilution, Hb by around 1 to 2 gm/dl.
DEFINITION (WHO) : Hb < 11 grams/dl.
INCIDENCE : Affects > 40% P.W. world wide.
DETERMINE : Severity : Mild: Hb 10-10.9 gm/dl, Mod: 7.0-9.9 gm/dl,
Severe: 4-6.9 gm/dl, Very Severe Hb < 4 gm/dl.
Type e.g. Microcytic Hypochromic.
Causes e.g. Iron-Deficiency.
SINGNIFICANCE :
1) Severe Anaemia contributes to and increases risk of death in P.W. (Maternal
Mortality).
2) Increases ill Health (Morbidity) e.g. Increases Susceptibility to Infections,
Increases need for Blood Transfusion, Increases risk of Postpartum Depression.
3) Increases Obstetric Complications e.g. Pre-eclampsia, Abruptio-Placentae,
Preterm Birth, LBW babies.
4) Increases Adverse Fetal Outcome – FGR, PNMR.
5) Newborn: Increased NMR, Abnormal Auditory Maturation.
6) Child : Impaired Psychomotor & Mental Development, Increased Cognitive &
behavioral abnormalities.
TREATMENT : IRON DEFICIENCY ANAEMIA
DIET : Green Leafy Vegetables, Jaggery.
DEWORMING : Albendazole, Mebendazole, after 13 weeks.
TREATMENT :
ORAL IRON : Elemental Iron 100-200 mg/day.
Problems : Tolerance, Compliance, GI side effects.
Supportive treatment: For side effects like Constipation.
PARENTERAL IRON: I.V. Iron Sucrose.
I.V. Ferric Carboxymaltose.
BLOOD TRANSFUSION : Rarely required eg. If Hb < 6 grams% & patient is in Third
Trimester of Pregnancy.
INCREASE IN WBC COUNT : LEUKOCYTOSIS IN PREGNANCY
FUNCTIONS OF WBC : Fighting against Germs (micro-organisms).
PHYSIOLOGICAL : Total WBC (White Blood Cell) Count increases in pregnancy, particularly the
Neutrophils, to help her fight against germs.
Especially when she is nearing EDD, during Labour & during puerperium.
WBC count upto 15,000/cumm is normal, especially Near Term During Labour,
WBC count 25,000/cumm is normal.
PATHOLOGICAL : Severe Pre-eclampsia.
CAUSES Stress, Intense Exercise, Trauma, Surgery.
Antenatal Infections : Cold, UTI, Eye Infections.
Infection During Labour or During Puerperium, Autoimmune disease like
Rheumatoid Arthritis, SLE.
TREATMENT : According to the cause, e.g. UTI-Urine C/S – Appropriate Antibiotics
Supportive care – Paracetamol for fever , personal Hygeine, Improving Immunity.
DECREASE IN PLATELET COUNT : THROMBOCYTOPENIA IN PREGNANCY
FUNCTION OF PLATELET : Help in and facilitating Blood Clotting Process.
PHYSIOLOGICAL : Platelet Count decreases in 10% pf P.W. especially between 30 & 40 weeks
to level below 1,50,000/cumm.
CHARACTERISTICS : No H/o low Platelet Count before conceiving, count is >70,000/cumm, No
H/o Bleeding, Count returns to normal within 12 weeks after delivery.
CRITICAL VALUE in Pregnancy is <1,00,000/cumm.
PATHOLOGICAL : Malaria, Dengue.
Pre-eclampsia, HELLP Syndrome (21%).
Immune Thrombocytopenia (ITP) 4%.
Less common: SLE,ALPA,TTP-HUS, Acute Fatty Liver of Pregnancy, DIC, HIV
infection, Hypersplenism & Medications.
TREATMENT : According to the cause.
ABO BLOOD GROUP & Rh TYPE
BLOOD GROUPS : A, B, AB, O.
Rh TYPES : Rh Positive, Rh Negative.
SIGNIFICANCE : In some complications during pregnancy, Labour or Puerperium, P.W. may require
Blood Transfusion.
If Pregnant women is Rh-Negative, Certain additional investigations & treatment
are required.
Inj. Anti D 300 mcg at 28 weeks Monitor P.W. with Col.Doppler MCA-PSA
After Delivery
Newborn’s Blood group IUT SOS, Timely Delivery.
No Further Action Adm. Inj Anti D 300 mcg to P.Mother within 72 hours
Watch for NB Jaundice -> Management-Phototherapy
P.W IS Rh Negative
Test her Husband-Blood group & Rh Type
Husband Rh Negative
No Further Test/Action
Husband Rh Positive
W:Anti Rh Ab – Early pr. & 28 weeks
Negative Positive
Rh Negative Rh Positive
HbA1C, BS-F & PP, DIPSI TEST , OGTT
AIM : To detect GDM-Gestational Diabetes Mellitus & Manage it.
To differentiate between PGDM-Pregestational Diabetes Mellitus & GDM if not
previously known to be Diabetic(PGDM); with the help of HbA1C in 1st Trimester.
To Identify women at the greatest risk for Congenital Malformations of fetus :from
HbA1C levels in 1st Trimester.
INCIDENCE : GDM 90% & PGDM 10% of all cases of Diabetes Mellitus in Pregnancy.
GDM in India 4 to 21 %
30% of GDM patients do not have risk factor, hence Universal screening is
recommended.
MALFORMATION RISK : Haemoglobin A1c Major Malformation
< 6% 2-3%
6-7 % 5-10%
8-10 % 10-25%
>10% >25%
METHODS :
HbA1C (GLYCOSYLATED HAEMOGLOBIN)
It represents glycaemic control (sugar level) in previous three months.
Hence it can differentiate GDM from PGDM if performed in 1st Trimester.
HbA1C > 6.5% in 1st Trimester – implies PGDM
Target : In each Trimester 6% or less.
BS (BLOODSUGAR) FASTING & PP (POST PRANDIAL)
Venous blood Sugar In 1st trim PGDM
Fasting : >126 mg/dl
Post Prandial : >200 mg/dl
Target: Fasting BS < 100 mg/dl.
2 hours Post Lunch <120 mg/dl.
DIPSI TEST
DIABETES IN PREGNANCY STUDY GROUP OF INDIA TEST
It is simple ,less cumbersome, cost effective, easily acceptable, efficient screening test, may be performed in
each trimester.
WHEN? : At first antenatal visit, then repeat between 24and 28 weeks.
HOW? : No need of fasting status.
75 gram of glucose mixed with 300 ml of water , is consumed by PW, slowly over 5 to 10 minutes,
after two hours test the blood glucose level. .
NORMAL : Blood glucose < 140 mg/dl.
CRITICAL : Blood glucose > 140 mg/dl – GDM 15% require OGTT to confirm diagnosis
: Blood glucose > 200 mg/dl – Diagnostic for GDM [ OGTT not needed]
NOTE It the vomits within 30 minutes after drinking, conduct the test on another day .
If PW vomits after 30 minutes of consumption, go on with the test.
OGTT
ORAL GLUCOSE TOLERANCE TEST
WHEN? : For definitive diagnosis of GDM.
If Random BS or DIPSI Test is 140-150 mg/dl.
At 28 weeks of pregnancy if first Trimester Screening was negative.
HOW? : 75 grams glucose challenge.
Fasting overnight for at least 8 hours (not > 14 hours).
CRITICAL VALUES : Venous glucose Concentration for diagnosis of DM
NDDG(mg/dl) Carpenter & Counstan(mg/dl)
Fasting 105 95
1-hour 190 180
2-hour 165 155
3-hour 145 140
--------------------------------------------------------------------------------------------------------------------------------------------------------
NDDG : National Diabetes Data Group
Carpenter & Coustan. Am J Ob Gyn 1982
WHY BOTHER TO SCREEN FOR GDM? CONSEQUENCES
I MATERNAL:
• Increased risk for Pre-eclampsia, Caesarean Delivery.
• 60% of GDM may develop over type 2 Diabetes Mellitus within 16 years, and may have shortened
life expectancy due to Cardiovascular disease.
II FETAL AND NEONATAL:
• Excessive fetal growth and birth trauma, including Shoulder Dystocia, Neonatal Hypoglycaemia,
Hypocalcaemia, Hyperbilirubinemia.
• Increased Perinatal Mortality associated with significant Maternal Hyperglycemia (uncontrolled) :
Class A2 Diabetes i.e. requiring Diet, Exercise & Insulin or Metformin.
ANTEPARTUM MANAGEMENT OF GDM
VISIT : 1-2 weeks until 36 weeks, then weekly.
DIET : 3 meals, bedtime snack.
2000-2200 Kcal/day.
Carbo 40-50% Protein 20%, Fat 30-40%, High fibre.
WEIGHT GAIN : Depending on BMI.
EXERCISE : Regular Exercise, 30 minutes moderate exercise (brisk walking).
SURVEILLANCE : SMBG- Self Monitoring of Capillary Blood Glucose.
If Fasting >95 mg/dl, 1 hour >140 mg/dl &/or 2 hour>120 mg/dl, Acid Insulin
(preferable) or Metformin.
INSULIN : 1st Trimester 0.8 u/kg 2nd Trimester 1.0 u/kg 3rd Trimester 1.2 u/kg.
50% as Basal Insulin (NPH)- 2/3rd fasting 1/3rd bedtime.
50% as Prandial Insulin (Insulin Lispro or As part).
METFORMIN : If patient refuses Insulin or If cost is the problem. 500 mg with dinner increases upto
1000 mg twice a day.
Side Effects : 10-25% transient GI side effects. 40% may need supplemental Insulin.
Does cross placenta, but no adverse Fetal/Neonatal/Child effects.
DELIVERY : Well controlled on Diet & Exercise ; 39-40 weeks.
suboptimally controlled – before 39 weeks.
PIH or Prior SB or class A2 NST twice a week from 32 weeks.
SFH & USG – W/F excessive fetal growth.
Wt > 4500 gm – LSCS
Wt 4000-4500 gm, consider prior obstetric history, pelvic capacity Alert Neonatal
Team- Hypoglycaemia, Hypocalacemia, Hyperbilirubinaemia.
Encourage breast feeding.
POST PARTUM CARE
SMBG 24-72 hours after delivery.
4-12 weeks fasting glucose or 75 gm oral GTT.
VALUES FOR VENOUS PLASMA GLUCOSE (mg/dl)
Time Normal Prediabetes Diabetes Mellitus
Fasting <100 100-125 >126
2 hrs after 75 gm <140 140-199 > 200
If normal, evaluate annually Fasting or HbA1C and every 1-3 years with 75 gm OGTT.
Encourage exercise & if obese, weight loss.
OCs : Low dose pills-No Carbohydrate intolerance.
RECURRENCE RISK IN SUBSEQUENT PREGNANCIES 40-60%
Testing for GDM in subsequent pregnancies.
THANK YOU

More Related Content

Similar to Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosis, Thrombocytopenia and GDM

HYPERTENSIVE DISORDERS OF PREGNANCY.pptx
HYPERTENSIVE DISORDERS OF PREGNANCY.pptxHYPERTENSIVE DISORDERS OF PREGNANCY.pptx
HYPERTENSIVE DISORDERS OF PREGNANCY.pptx
ssuser52ada61
 
gdm (1).pptx
gdm (1).pptxgdm (1).pptx
gdm (1).pptx
AnithaAldur
 
Pregestational Diabetes- Modern + Ayurveda aspect
Pregestational Diabetes- Modern + Ayurveda aspectPregestational Diabetes- Modern + Ayurveda aspect
Pregestational Diabetes- Modern + Ayurveda aspect
DrPriyankaHajare1
 
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in  pregnancy ( Preeclampsia ) : recent guidelinesHypertension in  pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
Omar Khaled
 
Obs Study Guide 3
Obs Study Guide 3Obs Study Guide 3
Obs Study Guide 3
Ailleen
 
gdm (1).pptx
gdm (1).pptxgdm (1).pptx
gdm (1).pptx
AnithaAldur
 
Gastrocon 2016 - Pregnancy & Liver Disease
Gastrocon 2016 - Pregnancy & Liver DiseaseGastrocon 2016 - Pregnancy & Liver Disease
Gastrocon 2016 - Pregnancy & Liver Disease
ApolloGleaneagls
 
Diabetes in Pregnancy
Diabetes in PregnancyDiabetes in Pregnancy
Diabetes in Pregnancy
Shashikiran Umakanth
 
Management of diabetes in pregnancy
Management of diabetes in pregnancyManagement of diabetes in pregnancy
Management of diabetes in pregnancy
Sharon Treesa Antony
 
Baseline serum chemistry in 1st trimester
Baseline serum chemistry in 1st trimesterBaseline serum chemistry in 1st trimester
Baseline serum chemistry in 1st trimester
Rohit Jain
 
Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''
Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''
Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''
Nassr ALBarhi
 
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermApproach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermDang Thanh Tuan
 
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermApproach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermDang Thanh Tuan
 
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermApproach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermDang Thanh Tuan
 
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermApproach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermDang Thanh Tuan
 
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermApproach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermDang Thanh Tuan
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In PregnancyMarga artes
 

Similar to Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosis, Thrombocytopenia and GDM (20)

Diabetes In Pregnancy[1]
Diabetes In Pregnancy[1]Diabetes In Pregnancy[1]
Diabetes In Pregnancy[1]
 
HYPERTENSIVE DISORDERS OF PREGNANCY.pptx
HYPERTENSIVE DISORDERS OF PREGNANCY.pptxHYPERTENSIVE DISORDERS OF PREGNANCY.pptx
HYPERTENSIVE DISORDERS OF PREGNANCY.pptx
 
gdm (1).pptx
gdm (1).pptxgdm (1).pptx
gdm (1).pptx
 
Pregestational Diabetes- Modern + Ayurveda aspect
Pregestational Diabetes- Modern + Ayurveda aspectPregestational Diabetes- Modern + Ayurveda aspect
Pregestational Diabetes- Modern + Ayurveda aspect
 
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in  pregnancy ( Preeclampsia ) : recent guidelinesHypertension in  pregnancy ( Preeclampsia ) : recent guidelines
Hypertension in pregnancy ( Preeclampsia ) : recent guidelines
 
Obs Study Guide 3
Obs Study Guide 3Obs Study Guide 3
Obs Study Guide 3
 
gdm (1).pptx
gdm (1).pptxgdm (1).pptx
gdm (1).pptx
 
Gastrocon 2016 - Pregnancy & Liver Disease
Gastrocon 2016 - Pregnancy & Liver DiseaseGastrocon 2016 - Pregnancy & Liver Disease
Gastrocon 2016 - Pregnancy & Liver Disease
 
Gestational Diabetes
Gestational DiabetesGestational Diabetes
Gestational Diabetes
 
Diabetes in Pregnancy
Diabetes in PregnancyDiabetes in Pregnancy
Diabetes in Pregnancy
 
Management of diabetes in pregnancy
Management of diabetes in pregnancyManagement of diabetes in pregnancy
Management of diabetes in pregnancy
 
Baseline serum chemistry in 1st trimester
Baseline serum chemistry in 1st trimesterBaseline serum chemistry in 1st trimester
Baseline serum chemistry in 1st trimester
 
Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''
Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''
Diabetes Mellitus in pregnancy " Gestational diabetes mellitus''
 
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermApproach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In Term
 
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermApproach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In Term
 
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermApproach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In Term
 
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermApproach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In Term
 
Approach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In TermApproach To The Management Of Hyperbilirubinemia In Term
Approach To The Management Of Hyperbilirubinemia In Term
 
Polycystic ovary
Polycystic ovaryPolycystic ovary
Polycystic ovary
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
 

More from DrNisheethOza

18 - 22 Weeks Anomaly Scan
18 - 22 Weeks Anomaly Scan18 - 22 Weeks Anomaly Scan
18 - 22 Weeks Anomaly Scan
DrNisheethOza
 
प्रसूतिकी सही तारीख (EDD) कैसे तय करें?
प्रसूतिकी सही तारीख (EDD) कैसे तय करें?प्रसूतिकी सही तारीख (EDD) कैसे तय करें?
प्रसूतिकी सही तारीख (EDD) कैसे तय करें?
DrNisheethOza
 
How to find out Correct EDD?
How to find out Correct EDD?How to find out Correct EDD?
How to find out Correct EDD?
DrNisheethOza
 
Pregnancy में Ultrasonography Scan
Pregnancy  में Ultrasonography  ScanPregnancy  में Ultrasonography  Scan
Pregnancy में Ultrasonography Scan
DrNisheethOza
 
Ultrasonography Scans in Pregnancy
Ultrasonography Scans in PregnancyUltrasonography Scans in Pregnancy
Ultrasonography Scans in Pregnancy
DrNisheethOza
 
NT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILENT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILE
DrNisheethOza
 

More from DrNisheethOza (6)

18 - 22 Weeks Anomaly Scan
18 - 22 Weeks Anomaly Scan18 - 22 Weeks Anomaly Scan
18 - 22 Weeks Anomaly Scan
 
प्रसूतिकी सही तारीख (EDD) कैसे तय करें?
प्रसूतिकी सही तारीख (EDD) कैसे तय करें?प्रसूतिकी सही तारीख (EDD) कैसे तय करें?
प्रसूतिकी सही तारीख (EDD) कैसे तय करें?
 
How to find out Correct EDD?
How to find out Correct EDD?How to find out Correct EDD?
How to find out Correct EDD?
 
Pregnancy में Ultrasonography Scan
Pregnancy  में Ultrasonography  ScanPregnancy  में Ultrasonography  Scan
Pregnancy में Ultrasonography Scan
 
Ultrasonography Scans in Pregnancy
Ultrasonography Scans in PregnancyUltrasonography Scans in Pregnancy
Ultrasonography Scans in Pregnancy
 
NT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILENT SCAN (11-13.6 weeks) & Serum BIOPROFILE
NT SCAN (11-13.6 weeks) & Serum BIOPROFILE
 

Recently uploaded

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 

Recently uploaded (20)

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 

Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosis, Thrombocytopenia and GDM

  • 1. COMMON LAB. INVESTIGATIONS IN PREGNANCY With specific reference to Anaemia, Leukocytosis, Thrombocytopenia, GDM. Dr. NISHEETH M. OZA
  • 2. Dr. Nisheeth M. Oza M.D., D.G.O., F.C.P.S., D.N.B., (M.N.A.M.S.) (OBGYN) D.A., M.B.B.S., Dip. YAN Obstetrician, Gynaecologist, Infertility Consultant, FMF Certified Ultrasonographer (FMF ID 145907) Licensed for Aneuploidy Screening NT, NB, DV, Cervix & PIH Screening. Diploma in Yoga, Ayurveda & Naturopathy Dr. Oza’s Hospital 87/7, Panvel 410206, Maharashtra India. Email : drnmozas@gmail.com Website : drozashospital.com YouTube : DrOzaConnects
  • 3. INTRODUCTION When a Lady visits her Doctor during her pregnancy, she may be asked to undergo certain Laboratory Investigations at several times, e.g. In her first visit, At 11-14 weeks, At 26-28 weeks, At 34-36 weeks, She may wonder as to Whether the Lab. Investigations are necessary? WHICH? WHEN? WHY?
  • 4. AIM OF LAB. INVESTIGATIONS – WHY? • As a part of Prenatal (Antenatal) Care. • To ascertain the well being of P.W. eg Her Haemoglobin test. • To find out the conditions that may increase the risk of complications eg GDM (BS/DIPSI Test), UTI (Urine C/S), Hypothyroidism (S. TSH). • To find out conditions that may need special care & management eg Rh Negative, Haemoglobinopathy or STI. • To find out the conditions that may modify the management of P.W. & her N.B. eg HIV positive.
  • 5. WHEN? • FIRST TRIMESTER/FIRST VISIT : Antenatal Profile – Antenatal Panel. May combine it with Genetic Screening Tests at 11-24 weeks. • SECOND TRIMESTER 24-48 WEEKS : GDM, UTI, Anaemia. • THIRD TRIMESTER 35-37 WEEKS : GBS (Group B Streptococcal Vaginal Culture). UTI, Anaemia, Pre-eclampsia.
  • 6. FIRST TRIMESTER/FIRST VISIT LAB. TESTS MOST IMPORTANT: HbA1C, S. TSH. MINIMUM : CBC, Bl. Group & Rh type, HbA1C/DIPSI Test, S.TSH. Urine-R/M including Dipstick (Protein, Sugar, Pus cells, Nitrite). PREFERABLE : HIV, HBsAg, HCV, VDRL. BT, CT, PT. Urine C/S. OFFERED : Hb Electrophoresis – Abnormal Hb Study (Hb HPLC). Rapid Malaria Test (kit), Thick & Thin Smear. PAP Smear (Cytology). Rubella IgG. FUTURE : COVID-19 IgG, IgM. Note: These may be combined with Genetic Screening Tests recommended between 11and 14 weeks, If not performed prior to that.
  • 7. SECOND TRIMESTER: 24-28 WEEKS • CBC • DIPSI TEST, SOS OGTT • Urine Dipstick (Protein, Sugar, Pus Cells, Nitrate) THIRD TRIMESTER: 35-37 WEEKS • CBC • Urine Dipstick (Protein, Sugar, Pus Cells, Nitrate) • SOS Serum Creatinine, Serum Uric Acid • Group B Streptococcal Vaginal Culture (GBS) • Before Delivery : As per prevailing Protocol : COVID-19 rt PCR.
  • 8. WHICH TESTS ? WHAT IS THE SIGNIFICANCE? A] CBC COMPONENT CRITICAL VALUE FUNCTIONS Hb < 8 grams% Carrying Oxygen to Tissues. WBC > 15,000/cu mm Fighting against Germs. Platelet Count < 1,00,000/ cu mm Facilitate Blood Clotting. Mentzer Index < 13 Indicates Possibility of Haemoglobinopathy.
  • 9. LOW HB LEVEL: ANAEMIA IN PREGNANCY FUNCTION OF Hb : Carrying Oxygen to Tissues of P.W. & her fetus. PHYSIOLOGICAL : Plasma Volume(Liq. Component), more (50%) then RBC Vol. CHANGES (Solid Component) (30%), thereby Haemodilution, Hb by around 1 to 2 gm/dl. DEFINITION (WHO) : Hb < 11 grams/dl. INCIDENCE : Affects > 40% P.W. world wide. DETERMINE : Severity : Mild: Hb 10-10.9 gm/dl, Mod: 7.0-9.9 gm/dl, Severe: 4-6.9 gm/dl, Very Severe Hb < 4 gm/dl. Type e.g. Microcytic Hypochromic. Causes e.g. Iron-Deficiency.
  • 10. SINGNIFICANCE : 1) Severe Anaemia contributes to and increases risk of death in P.W. (Maternal Mortality). 2) Increases ill Health (Morbidity) e.g. Increases Susceptibility to Infections, Increases need for Blood Transfusion, Increases risk of Postpartum Depression. 3) Increases Obstetric Complications e.g. Pre-eclampsia, Abruptio-Placentae, Preterm Birth, LBW babies. 4) Increases Adverse Fetal Outcome – FGR, PNMR. 5) Newborn: Increased NMR, Abnormal Auditory Maturation. 6) Child : Impaired Psychomotor & Mental Development, Increased Cognitive & behavioral abnormalities.
  • 11. TREATMENT : IRON DEFICIENCY ANAEMIA DIET : Green Leafy Vegetables, Jaggery. DEWORMING : Albendazole, Mebendazole, after 13 weeks. TREATMENT : ORAL IRON : Elemental Iron 100-200 mg/day. Problems : Tolerance, Compliance, GI side effects. Supportive treatment: For side effects like Constipation. PARENTERAL IRON: I.V. Iron Sucrose. I.V. Ferric Carboxymaltose. BLOOD TRANSFUSION : Rarely required eg. If Hb < 6 grams% & patient is in Third Trimester of Pregnancy.
  • 12. INCREASE IN WBC COUNT : LEUKOCYTOSIS IN PREGNANCY FUNCTIONS OF WBC : Fighting against Germs (micro-organisms). PHYSIOLOGICAL : Total WBC (White Blood Cell) Count increases in pregnancy, particularly the Neutrophils, to help her fight against germs. Especially when she is nearing EDD, during Labour & during puerperium. WBC count upto 15,000/cumm is normal, especially Near Term During Labour, WBC count 25,000/cumm is normal. PATHOLOGICAL : Severe Pre-eclampsia. CAUSES Stress, Intense Exercise, Trauma, Surgery. Antenatal Infections : Cold, UTI, Eye Infections. Infection During Labour or During Puerperium, Autoimmune disease like Rheumatoid Arthritis, SLE. TREATMENT : According to the cause, e.g. UTI-Urine C/S – Appropriate Antibiotics Supportive care – Paracetamol for fever , personal Hygeine, Improving Immunity.
  • 13. DECREASE IN PLATELET COUNT : THROMBOCYTOPENIA IN PREGNANCY FUNCTION OF PLATELET : Help in and facilitating Blood Clotting Process. PHYSIOLOGICAL : Platelet Count decreases in 10% pf P.W. especially between 30 & 40 weeks to level below 1,50,000/cumm. CHARACTERISTICS : No H/o low Platelet Count before conceiving, count is >70,000/cumm, No H/o Bleeding, Count returns to normal within 12 weeks after delivery. CRITICAL VALUE in Pregnancy is <1,00,000/cumm. PATHOLOGICAL : Malaria, Dengue. Pre-eclampsia, HELLP Syndrome (21%). Immune Thrombocytopenia (ITP) 4%. Less common: SLE,ALPA,TTP-HUS, Acute Fatty Liver of Pregnancy, DIC, HIV infection, Hypersplenism & Medications. TREATMENT : According to the cause.
  • 14. ABO BLOOD GROUP & Rh TYPE BLOOD GROUPS : A, B, AB, O. Rh TYPES : Rh Positive, Rh Negative. SIGNIFICANCE : In some complications during pregnancy, Labour or Puerperium, P.W. may require Blood Transfusion. If Pregnant women is Rh-Negative, Certain additional investigations & treatment are required.
  • 15. Inj. Anti D 300 mcg at 28 weeks Monitor P.W. with Col.Doppler MCA-PSA After Delivery Newborn’s Blood group IUT SOS, Timely Delivery. No Further Action Adm. Inj Anti D 300 mcg to P.Mother within 72 hours Watch for NB Jaundice -> Management-Phototherapy P.W IS Rh Negative Test her Husband-Blood group & Rh Type Husband Rh Negative No Further Test/Action Husband Rh Positive W:Anti Rh Ab – Early pr. & 28 weeks Negative Positive Rh Negative Rh Positive
  • 16. HbA1C, BS-F & PP, DIPSI TEST , OGTT AIM : To detect GDM-Gestational Diabetes Mellitus & Manage it. To differentiate between PGDM-Pregestational Diabetes Mellitus & GDM if not previously known to be Diabetic(PGDM); with the help of HbA1C in 1st Trimester. To Identify women at the greatest risk for Congenital Malformations of fetus :from HbA1C levels in 1st Trimester. INCIDENCE : GDM 90% & PGDM 10% of all cases of Diabetes Mellitus in Pregnancy. GDM in India 4 to 21 % 30% of GDM patients do not have risk factor, hence Universal screening is recommended.
  • 17. MALFORMATION RISK : Haemoglobin A1c Major Malformation < 6% 2-3% 6-7 % 5-10% 8-10 % 10-25% >10% >25% METHODS : HbA1C (GLYCOSYLATED HAEMOGLOBIN) It represents glycaemic control (sugar level) in previous three months. Hence it can differentiate GDM from PGDM if performed in 1st Trimester. HbA1C > 6.5% in 1st Trimester – implies PGDM Target : In each Trimester 6% or less. BS (BLOODSUGAR) FASTING & PP (POST PRANDIAL) Venous blood Sugar In 1st trim PGDM Fasting : >126 mg/dl Post Prandial : >200 mg/dl Target: Fasting BS < 100 mg/dl. 2 hours Post Lunch <120 mg/dl.
  • 18. DIPSI TEST DIABETES IN PREGNANCY STUDY GROUP OF INDIA TEST It is simple ,less cumbersome, cost effective, easily acceptable, efficient screening test, may be performed in each trimester. WHEN? : At first antenatal visit, then repeat between 24and 28 weeks. HOW? : No need of fasting status. 75 gram of glucose mixed with 300 ml of water , is consumed by PW, slowly over 5 to 10 minutes, after two hours test the blood glucose level. . NORMAL : Blood glucose < 140 mg/dl. CRITICAL : Blood glucose > 140 mg/dl – GDM 15% require OGTT to confirm diagnosis : Blood glucose > 200 mg/dl – Diagnostic for GDM [ OGTT not needed] NOTE It the vomits within 30 minutes after drinking, conduct the test on another day . If PW vomits after 30 minutes of consumption, go on with the test.
  • 19. OGTT ORAL GLUCOSE TOLERANCE TEST WHEN? : For definitive diagnosis of GDM. If Random BS or DIPSI Test is 140-150 mg/dl. At 28 weeks of pregnancy if first Trimester Screening was negative. HOW? : 75 grams glucose challenge. Fasting overnight for at least 8 hours (not > 14 hours). CRITICAL VALUES : Venous glucose Concentration for diagnosis of DM NDDG(mg/dl) Carpenter & Counstan(mg/dl) Fasting 105 95 1-hour 190 180 2-hour 165 155 3-hour 145 140 -------------------------------------------------------------------------------------------------------------------------------------------------------- NDDG : National Diabetes Data Group Carpenter & Coustan. Am J Ob Gyn 1982
  • 20. WHY BOTHER TO SCREEN FOR GDM? CONSEQUENCES I MATERNAL: • Increased risk for Pre-eclampsia, Caesarean Delivery. • 60% of GDM may develop over type 2 Diabetes Mellitus within 16 years, and may have shortened life expectancy due to Cardiovascular disease. II FETAL AND NEONATAL: • Excessive fetal growth and birth trauma, including Shoulder Dystocia, Neonatal Hypoglycaemia, Hypocalcaemia, Hyperbilirubinemia. • Increased Perinatal Mortality associated with significant Maternal Hyperglycemia (uncontrolled) : Class A2 Diabetes i.e. requiring Diet, Exercise & Insulin or Metformin.
  • 21. ANTEPARTUM MANAGEMENT OF GDM VISIT : 1-2 weeks until 36 weeks, then weekly. DIET : 3 meals, bedtime snack. 2000-2200 Kcal/day. Carbo 40-50% Protein 20%, Fat 30-40%, High fibre. WEIGHT GAIN : Depending on BMI. EXERCISE : Regular Exercise, 30 minutes moderate exercise (brisk walking). SURVEILLANCE : SMBG- Self Monitoring of Capillary Blood Glucose. If Fasting >95 mg/dl, 1 hour >140 mg/dl &/or 2 hour>120 mg/dl, Acid Insulin (preferable) or Metformin. INSULIN : 1st Trimester 0.8 u/kg 2nd Trimester 1.0 u/kg 3rd Trimester 1.2 u/kg. 50% as Basal Insulin (NPH)- 2/3rd fasting 1/3rd bedtime. 50% as Prandial Insulin (Insulin Lispro or As part).
  • 22. METFORMIN : If patient refuses Insulin or If cost is the problem. 500 mg with dinner increases upto 1000 mg twice a day. Side Effects : 10-25% transient GI side effects. 40% may need supplemental Insulin. Does cross placenta, but no adverse Fetal/Neonatal/Child effects. DELIVERY : Well controlled on Diet & Exercise ; 39-40 weeks. suboptimally controlled – before 39 weeks. PIH or Prior SB or class A2 NST twice a week from 32 weeks. SFH & USG – W/F excessive fetal growth. Wt > 4500 gm – LSCS Wt 4000-4500 gm, consider prior obstetric history, pelvic capacity Alert Neonatal Team- Hypoglycaemia, Hypocalacemia, Hyperbilirubinaemia. Encourage breast feeding.
  • 23. POST PARTUM CARE SMBG 24-72 hours after delivery. 4-12 weeks fasting glucose or 75 gm oral GTT. VALUES FOR VENOUS PLASMA GLUCOSE (mg/dl) Time Normal Prediabetes Diabetes Mellitus Fasting <100 100-125 >126 2 hrs after 75 gm <140 140-199 > 200 If normal, evaluate annually Fasting or HbA1C and every 1-3 years with 75 gm OGTT. Encourage exercise & if obese, weight loss. OCs : Low dose pills-No Carbohydrate intolerance. RECURRENCE RISK IN SUBSEQUENT PREGNANCIES 40-60% Testing for GDM in subsequent pregnancies.